These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26035807)

  • 1. Square-Wave Ocular Oscillation and Ataxia in an Anti-GAD-Positive Individual With Hypothyroidism.
    Brokalaki C; Kararizou E; Dimitrakopoulos A; Evdokimidis I; Anagnostou E
    J Neuroophthalmol; 2015 Dec; 35(4):390-5. PubMed ID: 26035807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
    Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
    Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opsoclonus-myoclonus-ataxia syndrome with autoantibodies to glutamic acid decarboxylase.
    Markakis I; Alexiou E; Xifaras M; Gekas G; Rombos A
    Clin Neurol Neurosurg; 2008 Jun; 110(6):619-21. PubMed ID: 18433986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous downbeat nystagmus as a clue for the diagnosis of ataxia associated with anti-GAD antibodies.
    Vale TC; Pedroso JL; Alquéres RA; Dutra LA; Barsottini OG
    J Neurol Sci; 2015 Dec; 359(1-2):21-3. PubMed ID: 26671081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
    Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
    Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Cerebellar Ataxia Associated with Anti-glutamic Acid Decarboxylase Antibodies Mimicking Miller Fisher Syndrome.
    Nakamura Y; Nakajima H; Hosokawa T; Yamane K; Ishida S; Kimura F
    Intern Med; 2018 Jan; 57(2):269-271. PubMed ID: 29093402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of anti-GAD antibodies in abnormal eye movements.
    Tilikete C; Vighetto A; Trouillas P; Honnorat J
    Ann N Y Acad Sci; 2005 Apr; 1039():446-54. PubMed ID: 15826997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lesson of the month 2: Autoimmune sequelae of anti-GAD antibodies - thinking outside the box.
    Ward RJ; Varughese GI; Jose B; Abraham RJ
    Clin Med (Lond); 2017 Oct; 17(5):473-474. PubMed ID: 28974603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A new case of cerebellar ataxia with anti-GAD antibodies treated with corticosteroids and initially seronegative].
    Birand B; Cabre P; Bonnan M; Olindo S; Smadja D
    Rev Med Interne; 2006 Aug; 27(8):616-9. PubMed ID: 16797794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-GAD antibodies in paraneoplastic cerebellar ataxia associated with limbic encephalitis and autonomic dysfunction].
    Carra-Dalliere C; Thouvenot E; Bonafé A; Ducray F; Touchon J; Charif M
    Rev Neurol (Paris); 2012 Apr; 168(4):363-6. PubMed ID: 22405456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opsoclonus in a patient with increased titers of anti-GAD antibody provides proof for the conductance-based model of saccadic oscillations.
    Shaikh AG; Wilmot G
    J Neurol Sci; 2016 Mar; 362():169-73. PubMed ID: 26944142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebellar ataxia associated to anti-glutamic acid decarboxylase autoantibody (anti-GAD): partial improvement with intravenous immunoglobulin therapy.
    Pedroso JL; Braga-Neto P; Dutra LA; Barsottini OG
    Arq Neuropsiquiatr; 2011 Dec; 69(6):993. PubMed ID: 22297896
    [No Abstract]   [Full Text] [Related]  

  • 13. Cerebellar ataxia and autoantibodies restricted to glutamic acid decarboxylase 67 (GAD67).
    Guasp M; Solà-Valls N; Martínez-Hernández E; Gil MP; González C; Brieva L; Saiz A; Dalmau J; Graus F; Ariño H
    J Neuroimmunol; 2016 Nov; 300():15-17. PubMed ID: 27806870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of oral corticosteroids therapy in anti-glutamic acid decarboxylase antibodies cerebellar ataxia.
    di Biase L; Assenza G; Iorio R; Melgari JM; Salomone G; Marano M; Muda AO; Di Lazzaro V
    Parkinsonism Relat Disord; 2016 Sep; 30():78-80. PubMed ID: 27236207
    [No Abstract]   [Full Text] [Related]  

  • 15. A Rare Case of Cerebellar Ataxia Due to Voltage-Gated Calcium Channel and Glutamic Acid Decarboxylase Autoantibodies.
    Annunziata G; Lobo P; Carbuccia C
    Am J Case Rep; 2017 Nov; 18():1251-1255. PubMed ID: 29176543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies.
    Vulliemoz S; Vanini G; Truffert A; Chizzolini C; Seeck M
    J Neurol Neurosurg Psychiatry; 2007 Feb; 78(2):187-9. PubMed ID: 17229747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebellar ataxia associated with anti-glutamic acid decarboxylase autoantibodies.
    Vianello M; Tavolato B; Armani M; Giometto B
    Cerebellum; 2003; 2(1):77-9. PubMed ID: 12882238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebellar ataxia and epilepsy with anti-GAD antibodies: treatment with IVIG and plasmapheresis.
    Georgieva Z; Parton M
    BMJ Case Rep; 2014 Jan; 2014():. PubMed ID: 24419643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Steroid treatment in four cases of anti-GAD cerebellar ataxia].
    Bonnan M; Cabre P; Olindo S; Signate A; Saint-Vil M; Smadja D
    Rev Neurol (Paris); 2008 May; 164(5):427-33. PubMed ID: 18555874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-Titre GAD Antibody-Associated Late-Onset Cerebellar Ataxia with a Significant Clinical Response to Intravenous Immunoglobulin Treatment.
    Petrijan T; Menih M
    Cerebellum; 2017 Aug; 16(4):868-871. PubMed ID: 28321713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.